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Introduction
Aging is a complex physiologic process that involves a
number of biochemical reactions that lead to functional
impairment and increased pathology1. Aging is also
associated with a decline in immune function, known as
immunosenescence, that contributes to the increased
susceptibility to infection, cancer, and autoimmune dis-
eases observed in old organisms, including humans2,3.
Immunosenescence is reflected at the cellular, molecu-
lar, and genetic levels, with alterations of gene expres-
sion4 that may be due to a decreased capacity of the
immune system to respond to antigenic stimulation,
altered cytokine microenvironment, and impairment
of both innate and adaptive immunity5.
The immune system exhibits increased deterio-
ration with age and undergoes significant age-related
changes1,6. In this context, recent advances have focused
on natural killer (NK) and natural killer T (NKT) cells,
which have been suggested as a bridge between the
innate response and the adaptive system7. NK and NKT
cells with cytotoxic activity directly kill the target cells
and play a pivotal role in providing signals to initiate
the adaptive immune response. Age-related alterations
of the cellular components of innate immunity might
therefore be involved in the impairment of adaptive
immunity observed in the elderly2. Age is associated
with an increased morbidity to virus infections as well
as delay in the clearance of symptoms after infection,
which may cause changes in the innate response to the
production of and response to interferon (IFN) and cyto-
toxicity to NK cells8. Speziali et al.9 reported that age-
associated changes in CD16+IFN-γ+ NK cells may play a
role in controlling (reducing) parasitic infection intensity
in the elderly in Brazil. As for the other diseases like
depressive symptoms, Tsuboi et al.10 showed that well-
preserved NK cell cytotoxicity and increased NK num-
bers have a significant association with low depressive
symptoms and more life satisfaction in elderly women.
More and more aging-related diseases are reported
(Table 1), e.g., Parkinson’s disease11,12, osteoporosis13,
cancers14 , and Alzheimer’s disease (AD)15–17. Among
these, AD, with the contribution of immunologic fac-
tors in the etiopathogenesis, is increasingly noted. In
order to clarify the altered lymphocyte distribution in
AD, Richartz-Salzburger et al.15 investigated a sample
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of 43 patients with AD and of 34 healthy age-matched
controls for the distribution of the T, B, and NK cell
subsets. The results demonstrated a significant decrease
in numbers of T (CD3+ and CD8+) and B (CD19+) cells in
AD, sustaining the hypothesis of a general decline of
immune activity in AD. The number of NK (CD16+,
CD56+) cells was not altered15. However, other studies
found decreased circulating concentrations of CD8+ lym-
phocytes and NK cell activity in AD patients16. Thus, there
is a putative association with premature immunosenes-
cence and possible pathogenetic implications in AD17.
In this review, we report on the role played by NK
and NKT cells during aging and the changes that lead
to healthy aging and longevity. Finally, potential ther-
apeutic strategies and nutrients in regulating NK/NKT
cells and aging are also discussed.
NK/NKT Cells and Aging
NK cells
NK cells, a kind of antigen-nonspecific lymphocytes,
play an important role in anti-viral immunity18. NK
cells kill abnormal cells and orchestrate subsequent
adaptive T and B lymphocyte immune responses. NK
activation is controlled by a balance of signals from
stimulatory receptors and major histocompatibility
complex (MHC) class I-specific inhibitory receptors19.
When NK cells respond to virus-infected cells and can-
cer cells, they will express down-regulated MHC class I
molecules and up-regulated NK stimulatory receptor
signals. The most important MHC class I-specific recep-
tors, CD94/NKG2 and KIR, are expressed by most NK cells
and a minority of T cells. CD94/NKG2 receptors are het-
erodimers composed of an invariant CD94 chain that
is paired with NKG2A, NKG2C, NKG2E, and possibly other
NKG2 family members, and NKG2 members are either
inhibitory (e.g., NKG2A) or stimulatory (e.g., NKG2C and
NKG2E)20.
The most characteristic function of NK cells is non-
MHC restricted killing of target cells, such as tumor, and
thus NK cells are important for maintaining health21.
The influence of aging to NK cells attributed to various
factors, such as decreased responsiveness to the positive
modulation with interleukin (IL)-222, could explain the
high frequency of cancer and infectious diseases with
aging. Low NK activity was found to be a good predic-
tor of morbidity23; the diminution of NK activity with
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Table 1. Aging-related diseases
Diseases Etiology Pathology Semiology Therapeutics Ref.
Alzheimer’s Genetic defect, β-amyloid plaque Thinking, understanding There are no known 15–17
disease environmental formation results in loss and decision-making treatments or medications
factors, etc. of cellular connections impairment, etc. for curing this disease; 
with other neurons and estrogen replacement 
provocation of neuronal may slow the decline in 
death memory 
Parkinson’s Genetic defect, Cell degeneration and loss Slowing of emotional and There are no known 11, 12
disease environmental of pigmented neurons voluntary movements, treatments or medications
factors, etc. muscular rigidity, for curing this disease;
postural abnormality, levodopa (L-DOPA) 
and tremors treatment may reduce 
the progression
Osteoporosis Genetic defect, Thinning and weakening Thinning and weakening Preventable with a diet rich 13
environmental of bones, especially of bones to the point in calcium and vitamin D, 
factors, etc. bones in the hip, where they break and weight-bearing
spine, and wrist exercise; hormone 
replacement therapy
Cancers Genetic defect, Uncontrolled cancer cell Increased occurrence of Surgery, chemotherapy, 14
carcinogenic division and spread many cancers with radiotherapy, gene 
factors, etc. age, resulting in therapy, etc.
death and morbidity
aging has been reported in both experimental animals
and humans24.
NKT Cells
NKT cells are a subset of regulatory lymphocytes that
co-express cell surface receptors characteristic of both
T lymphocytes (e.g., CD3, α/β T-cell receptor [TCR]) and
NK cells (e.g., CD56, NK1.1)25. NKT (CD3+ CD56+) cells
have a very limited TCR repertoire, with a Vα14–Jα281
Vα chain and Vβ chains skewed to use of Vβ8.2, Vβ7,
and Vβ215,25. The activation of NKT cells is restricted to
the MHC-like molecule CD1d. Although the natural lig-
and for the receptor is not known, the receptor can be
detected by the binding of CD1d tetramers loaded with
a synthetic glycolipid, α-galactosylceramide (α-Gal-
Cer)26. After engagement of the TCR with α-Gal-Cer, the
cells rapidly secrete large amounts of IL-4 and IFN-γ,
suggesting that these cells play an important role in
regulating immune responses27. The contribution of
NKT cells to some microbial infections, such as Listeria
monocytogenes, Toxoplasma gondii and Cryptococcus
neoformans, which are controlled by cell-mediated
immunity, has been reported28–30. Blackstock et al.31
demonstrated that age-related resistance of C57BL/6
mice to C. neoformans is dependent on maturation of
NKT cells. The possible role for NKT cells was determined
by passive transfer of thymocytes from 10-week-old
mice (containing mature NKT cells) or 2-week-old mice
(containing immature NKT cells) to 6-week-old mice31.
Although the proportion of NKT cells was rather low,
they were tightly associated with aging and other T cells.
It has been shown that the ratio of CD4 to CD8 tends
to decrease among NKT (i.e., NK1.1+ CD3int) cells and T
cells at all intraepithelial sites in the intestine with age32.
Aging
The genetic theory of aging holds that several genes
are involved in longevity33. Up to 25% of the variation
in human life span is heritable34. In the several models
that are used to study aging, such as nematode worms
(Caenorhabditis elegans), fruit flies (Drosophila) and
mice, genetic mutations can increase the life span 
as much as sixfold, apparently by slowing the aging
process35. The exceptional longevity or life beyond the
age of 90 years appears to have an even stronger genetic
basis36, which can explain why centenarians and near-
centenarians tend to cluster in families.
Some “longevity genes” may be involved in pro-
longing the human life span, especially those related to
the inflammatory status, in particular pro-inflammatory
cytokines (IL-1, IL-6, and TNF-α), anti-inflammatory
cytokines (IL-10), and Hsp7037. Some other genes linked
to oxidative stress (PON1)38 or IGF1/insulin pathway37
seem related to the longevity, as well as the genes
involved in the regulation of DNA repair, nuclear struc-
ture, and telomere length33. However, the genes related
to inflammation seem particularly relevant taking into
account that the innate immunity is more involved
during inflammation, and a chronic inflammatory sta-
tus (called inflamm-aging) appears to be the major
component of the most common age-related diseases,
including cardiovascular diseases and infections37.
During aging, T cells acquire expression of mole-
cules usually associated with NK cells, including CD16,
CD56, CD57, and CD94. T cells with NK-associated mark-
ers are found in much smaller numbers in young
adults and are not identical to the regulatory NKT cells
that express the highly restricted Vα24 TCR39. Studies
have shown that T cells with NK-associated markers
from elderly subjects are hyporesponsive to antigen
stimulation39. An article reported that the number 
of extrathymic T cells surpasses of thymus-derived 
T cells in various immune organs of mice with aging40.
Congenitally athymic nude mice carry only a small
number of lymphocytes when young (i.e., up to 10
weeks) but acquire a considerable number of lympho-
cytes (i.e., extrathymic T cells) in the liver and at the
intraepithelial site of the intestine when old41. This is
because of the phenomenon in which extrathymic T
cells tend to increase as a function of age42. Ishimoto
et al.32 reported that in comparison with young mice
(4 weeks of age), the number of total lymphocytes
yielded by all tested organs was greater in adult (9 weeks)
and old (40 weeks) mice. Their results showed that
both the liver and intraepithelial sites in the intestine
carry many extrathymic T cells, the distribution of
lymphocyte subsets and their age-associated variation
are site-specific32. The major lymphocyte subset that
expanded with age was IL-2 receptor (IL-2R) β+CD3int
cells (50% of them expressed NK1.1) in the liver, whereas
it was CD3+IL-2Rβ−NK1.1− cells at all intraepithelial sites
in the intestine.
According to previous reports43, certain age-related
baseline differences in the composition of the periph-
eral lymphocyte pool were observed, including higher
numbers of NK cells and lower numbers of B cells and
CD45RA+CD4+ T cells in the elderly. Sfikakis et al.44
investigated the potential role of the adult thymus in
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T-cell homeostasis subsequent to lymphopenia, and
they found that the adult patients (n = 21; mean age,
30 years; range, 18–49) had higher baseline numbers
of B and lower numbers of NK cells than elderly
patients (n=15; mean age, 79 years; range 70–91), while
total T-cell numbers did not differ. However in
advanced age, although peripheral homeostatic path-
ways appear intact, regeneration of the naive repertoire
is incomplete44.
The Correlation Between NK/NKT 
Cells and Aging
The role of NK/NKT cells in aging
The ability of NK cells to exert cytotoxic function is
well preserved in our life until old age. High NK activ-
ity is a prerequisite of good health and longevity45.
Low NK activity in the elderly may be associated with
infectious diseases, such as influenza, the most impor-
tant of all infectious diseases46. The role of NK cells as
one of the immune mechanisms engaged in the pro-
tection and recovery from the infectious diseases as
well as vaccine efficacy in older people have been
linked to their health status47. Human NK cells recognize
the influenza virus hemagglutinins which can enhance
NK cytotoxic activity in vitro48. Even in volunteers
injected with the inactivated influenza virus vaccine,
an increase in NK cytotoxic activity has been reported
after vaccination49,50.
T cell functions and NK activity seem to be the
immune responses most affected by aging. De la Fuente 
et al.51 have studied the changes of several immune
functions with age in rats of both sexes. The results
showed that an age-related decrease was found in
lymphocyte chemotaxis, T lymphoproliferative response
to the mitogen ConA, IL-2 release, and NK activity of
cells from axillary nodes and spleen of male and female
rats, as well as of females ovariectomized at 12 months
of age have been studied. The data showed that a cer-
tain degree of immunosenescence takes place with
age in rats, with males being less immunocompetent
than intact age-matched females, but showing an
immune response similar to that of ovariectomized
animals51.
Receptors of NK/NKT cells in aging
Aging of the immune system is characterized by the con-
traction of the lymphocyte repertoire in the peripheral
circulation. TCR repertoire contraction is a likely cause 
of the decline in immunity with chronologic age as
evidenced by the increased morbidity and mortality 
to common and new infections, and the low rates of
protective responses to vaccination in the elderly. 
In vitro studies have demonstrated that senescent (or
pre-senescent) T cells and T cells of the aged express un-
usually high densities of the killer cell immunoglobulin-
like receptors (KIRs), the most diverse NK receptors
(NKRs), on NK cells. NKRs comprise a superfamily of
C-type lectin and Ig-like receptors that trigger either an
activating or inhibitory signal52. Several kinds of NKRs
that usually found on aging T cells and on T cells of the
aged are CD16 (i.e., FcγRIII), CD56 (i.e., NCAM), CD94,
CD161 (i.e., NKRP1A), NKG2D, and members of the KIR
family53. CD16, CD56, and KIRs are Ig-like NKRs, whereas
CD94, NKG2D, and CD161 are C-type lectin NKRs.
NK cells are essential for healthy aging, and their
activation is controlled by MHC class I-specific CD94/
NKG2 receptors and KIRs. Lutz et al.54 reported that an
age-related decrease was seen in CD94 and NKG2A ex-
pression and a reciprocal age-related increase in KIR
expression. However, neither NK activation nor cyto-
toxic granule release was mediated by CD16 with age.
NKG2A expression also declined with age on CD56+ T
cells. The distinct roles of CD94/NKG2A and KIR recep-
tors suggest that shifting MHC class I receptor expres-
sion patterns reflect age-related changes in NK cell and
CD56+ T cell turnover and function in vivo54.
KIRs, which constitute the largest family of human
NKRs with multiple inhibitory and activating mem-
bers, are commonly found on human NK cells, γδT
cells, and CD8 T cells55,56. The inhibitory receptors bind
classical human histocompatibility leukocyte antigen
(HLA) class I molecules and mediate “missing self” recog-
nition. The physiological ligands for the activating KIR
are unknown. The KIR family displays a high degree of
polymorphism; KIR haplotypes contain between five and
12 highly homologous KIR genes57, and up to nine alleles
for individual KIR genes58. The literature shows that KIRs
are associated with several diseases; KIR3DS1 and its
proposed ligand HLA-Bw4 confer resistance to the devel-
opment of full-onset AIDS in HIV-infected individuals59,
and the KIR2DS2 gene is associated with various autoim-
mune conditions, such as psoriatic arthritis60, diabetes61,
and vascular complications in rheumatoid arthritis62.
Aging is accompanied by deficits in both innate
immunity (NK function) and adaptive immunity (T-cell
function)62. Therefore, NKR induction on aging T cells
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confers the advantage for the integration of innate 
antigen-nonspecific immunity and adaptive/acquired 
antigen-specific immunity. NKR expression on T cells can
have profound impact on immunity. Abedin et al.63
showed that T cells are programmed to express NKRs/
KIRs, and T-cell clonal lineages express a variety of NKRs
toward the end stages of their replicative lifespan.
NKRs/KIRs comprise a diverse superfamily of receptors
whose induction in aging T cells is an adaptational
diversification of the immune repertoire, and the func-
tional diversity of these unusual NK-like T cells is cen-
tral to the creative development of new strategies to
enhance protective immunity in the aged53,63. As shown
in Table 2, robust antigen-specific immune responses are
attributed to a large pool of polyclonal (TCR-diverse) T
cells. TCR diversity is shaped by selection and maturation
processes in the thymus, the extent of diversity being
largely determined at birth. With the postnatal involu-
tion of the thymus and a lifetime exposure to antigens,
the naive compartment becomes restricted and the
memory compartment expands. With advancing age,
the T-cell repertoire becomes populated with highly
oligoclonal, long-lived T cells, a majority of which have
lost expression of CD28. Such CD28null T cells have lim-
ited or no proliferative capacity but are functionally
active53. Despite identical TCRs, these T cells of the
aged express a diversity of NKRs, exemplified by mem-
bers of the KIR family55, indicating functional diverse
subsets of cytotoxic KIR T cells (diverse subsets of T cells
with different NKR/KIR adornment).
Cytokines production
NK and NKT cells play a role in directing the differenti-
ation pathway (T helper 1 [Th1] vs. T helper 2 [Th2])
followed by CD4+ T cells after antigenic stimulation,
thus establishing a link between the innate and adap-
tive immunity. It was thought that NK cells secreted
IFN-γ and contributed to Th1 development, while NKT
cells secreted IL-4 and contributed to Th2 develop-
ment. However, later reports showed that NKT cells can
secrete both IL-4 and IFN-γ and contribute to the devel-
opment of the cell-mediated immune response31,64.
van Bergen et al.55 reported that the KIR+ CD4 cells, in
the absence of the Th2 marker CCR4, produced mainly
IFN-γ and little IL-4, IL-10 or IL-17 upon TCR triggering.
Moreover, the KIR-expressing CD4 T cells are predomi-
nantly HLA class II-restricted effector memory Th1 cells
with significant expression of KIR55.
The literature indicates that T-cell functions are the
most impaired with age, followed by NK cell activity65.
Biologically, the age-related decrease of T-cell prolifer-
ation, IL-2 production, and cytotoxicity could be related
to the low response of old animals to infections or
malignant cells24,66–68. Mariani et al.69 showed that the
ability of NK cells to synthesize chemotactic cytokines
upon stimulation by IL-12/IL-2, or to express the cor-
responding chemokine receptors in healthy human
with the age over 90 years are still maintained. However,
most investigations found that functional competence
of individual human NK cells declines with age32,70.
NK cells of aged people exhibited a diminished produc-
tion of IFN-γ and chemokines in response to IL-2 and
IL-670. Albright et al.71 also found that severe impair-
ment in the production of mRNA transcripts repre-
senting several cytokines in NK/lymphokine-activated
killer cells of aged mouse.
Age-related changes in leukocyte subsets and
impairment in lymphocyte functions, especially in 
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Table 2. Comparison of adaptational diversification of the immune repertoire (TCR-clonal NKR/KIR-diverse T cells) in different
age groups
Population Adaptational diversification Expression of surface molecules
Newborn ● Mostly naive, TCR-diverse ● CD28: highly expressed
● Polyclonal CD28+ ● KIR3DL2, KIR2DL4, CD16/CD56: not expressed
● Highly proliferative ● KIR-a/b/c, CD161, NKG2, KLRG1: not expressed
Young adult ● Reduced naive CD28+ ● CD28: moderately expressed
● Memory CD28null and CD28+ ● KIR3DL2, KIR2DL4, CD16/CD56: moderately expressed
● Oligoclonal NKR+CD28null ● KIR-a/b/c, CD161, NKG2, KLRG1: not expressed
Old adult ● Limited naive ● CD28: lowly expressed
● Memory CD28null and CD28+ ● KIR3DL2, KIR2DL4, CD16/CD56: highly expressed
● Clonal senescent NK-like CD28null ● KIR-a/b/c, CD161, NKG2, KLRG1: highly expressed
T-cell activities, have been observed72. In old age, a
decrease in the lymphoproliferative capacity, IL-2 pro-
duction, and NK activity has been found73, while pro-
inflammatory cytokines such as TNF-α increased74.
A study indicated that old mice (72 ± 2 weeks) showed a
decrease in proliferation, NK activity, and IL-2 release,
and increase in TNF-α; whereas in very old mice (128 ±
2 weeks), these functions were more similar to those
in the adults (24 ± 2 weeks)75.
Potential Strategies or Nutrients 
in Anti-aging by Regulating 
NK/NKT Cells
Exercise
It is well accepted that aging is characterized by a dimin-
ished ability to respond to stress76. Proper exercises
help to relax and eliminate stress-related physiologic
and psychologic diseases. Consistent reports of the
positive relationship between regular physical activity
and immunosenescence have generated much excite-
ment in the field of exercise immunology77. Athletes
have been found to have stronger immune function,
including the cytotoxicity of NK cells and proliferative
response of phytohemagglutinin-induced lympho-
cytes, as well as a lower prevalence and mortality from
cancers78. However, athletes are also at risk for what is
known as the overtraining syndrome. Prolonged heavy
exertion lasting beyond normal limits adversely
affects immunity, leading to increased susceptibility to
upper respiratory tract infections, gastroenteritis, lep-
tospirosis, herpes simplex, and viral hepatitis79. Woods
et al.80 reported that 6 months of supervised exercise
training can lead to nominal increases in some mea-
sures of immune function; NK cell cytolysis versus K562
cells tended to increase (p < 0.1) in the exercise group 
of previously sedentary elderly subjects. However, data
from similar studies conducted failed to reach a statis-
tical significance because of small sample sizes and
short exercise periods. Therefore, larger samples sizes
and longer intervention periods (i.e., 1 year) would be
needed to demonstrate the statistical significance in
NK response and aging, respectively. Moreover, studies
free from limitations (larger sample size, true seden-
tary control group, controlled for seasonal variation,
etc.) need to be carried out in order to definitively
determine the effects of exercise training on immune
measures among the elderly and younger people.
Nutrients
It has been reported that people consuming a Mediter-
ranean diet, including micronutrients like vitamins,
essential minerals and other compounds required in
small amounts for normal metabolism, display a better
health status with higher probability to escape some
age-related diseases and to reach healthy longevity82.
The deficiency of macro- and micronutrients in aging
is considered to be closely related to global impair-
ments of immune functions, metabolic harmony, and
antioxidant defence by external noxae with subsequent
appearance of age-related diseases82. Moreover, nutri-
tional factors may play a pivotal role for healthy aging
in which the combination of genetic factors is funda-
mental in order to better understand human longevity.
Several potential nutrients are listed as follows.
1. Melatonin
Many hormones that are associated with maintenance
of immune function also decline with advancing age
and the interrelationship between the endocrine sys-
tem and the immune system is considered to be of
crucial importance in normal human physiology and
in mediating age-associated degenerative diseases83.
The decline in the production of a number of hormones
associated with aging, such as growth hormone, estro-
gen, and dehydroepiandrosterone, as well as of the
pineal substance melatonin (N-acetyl-5-methoxytrypt-
amine), has been proposed to play a significant role in
contributing to immunosenesecence83. Melatonin has
been demonstrated to bear a general immunoen-
hancing effect in many animal species as well as in
humans84. Melatonin has significant immunomodula-
tory roles in immunocompromised states; for example,
Maestroni et al.85 first showed that inhibition of mela-
tonin synthesis causes inhibition of cellular and humoral
responses in mice. Melatonin is formed mainly in the
pineal gland of most mammals86; however, adminis-
tration of exogenous melatonin is also important in
both innate and cellular immunity. The chronic admin-
istration of melatonin augmented the spontaneous
NK cell activity and also the circulating number of NK
cells87. The increased NK cell number brought about
by melatonin administration was attributed partly to 
the increased production of cytokines by melatonin-
stimulated T helper cells. IL-2, IL-6, IL-12 and IFN-γ
have all been suggested as the possible cytokines that
mediate melatonin-induced increase of NK cell num-
ber1,88. Moreover, melatonin is a natural antioxidant
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which exerts its many physiologic actions (e.g., scav-
enging of free radicals, interaction with cytosol pro-
teins like calmodulin) by acting on membrane and
nuclear receptors, the cause of significant anti-aging
activities89.
2. Zinc
Zinc is one of the most important trace elements in our
bodies, and deficiencies in zinc also accompany many
diseases, such as gastrointestinal disorders, renal dis-
ease, sickle cell anemia, alcoholism, some cancer types,
AIDS, and burns90. More than 300 enzymes require of
zinc for the biological function, although its presence
in nature does not exceed 0.02%91. The major charac-
teristics of zinc include a highly concentrated charge
and rapid exchange of reactions, which enable zinc to
play a major biological role as a catalyst92. Zinc is pres-
ent in ‘‘zinc finger domains’’ of many proteins, pep-
tides, enzymes, hormones, transcriptional factors, and
cytokines, which act in maintaining body homeosta-
sis93. Zinc is required to maintain enzymatic activity of
inducible nitricoxide synthase94. Zinc regulates G0/G1
phase of cell cycle by means of cyclin/CDK complexes
in a dose dependent manner95. Zinc also regulates 
the balance between gene expression of matrix metal-
loproteinases (MMPs) and the tissue inhibitors of
metalloproteinases (TIMPs)93; the expression of MMP
genes is under the control of the TIMP gene products,
α2 macroglobulin and 13-amyloid precursor protein,
which encode zincfinger motifs96. Alterations in the
balance between MMPs and TIMPs or α2 macroglobulin
have been observed in cancer, infections, and aging96.
The relevance of zinc is strictly linked to special pro-
teins called metallothioneins (MTs). MT acts as an antiox-
idant which induces the transfer of zinc from MT-binding
sites to other lower affinity proteins through the reaction
of oxido-reduction. The redox properties of MTs and their
effect on zinc in the clusters are crucial for the protective
role of MTs in transient stress, as it may occur in young
adult age97. In contrast, their role is harmful in aging
because of the stress-like condition and the constant
oxidative damage98. MT sequesters zinc and prevents the
transfer to other proteins during aging. Abnormal high
levels of MT and low zinc ion bioavailability are observed
in syndromes of accelerated aging such as Down syn-
drome99. Moreover, low zinc ion bioavailability is a risk
factor for infection relapses in the elderly, who display
decreased immune functions100. Decreased chemo-
taxis by neutrophils and monocytes and impairment
of cell-mediated immune responses, including thymic
endocrine activity, NK activity and cytokine produc-
tion, were observed with zinc-deprived diets101. MTs play
a pivotal role in zinc-related cell homeostasis because
of their high affinity for this trace element, which is in
turn relevant against oxidative stress and for the effi-
ciency of the entire immune system, including NK cell
activity102. In aging, the liver extrathymic NK activity is
also reduced because of the major quota of zinc ions
bound with liver MTs in immunosuppressive persons103.
Zinc–gene interaction also affects some relevant
cytokines (IL-6 and TNF-α) and Hsp70 in aging, successful
aging (nonagenarians) and in some age-related diseases
(such as atherosclerosis and infections)104. Some regu-
latory or inhibitory transcription factors (Egr-1, Sp1, A20),
which, together with other zinc-regulated transcription
factors (NF-κβ, STAT, HSF-1), are involved in the regula-
tion of gene transcription of pro-inflammatory cytokines
(IL-6 and TNF-α) and Hsp70 during inflammation and
in the presence of antigenic stimuli105. Therefore, zinc
finger proteins are indispensable for transducing signals
from the cytokine receptors into expression of response
genes, and zinc deficiency in experimental animals or
during a chronic inflammatory status, such as in aging,
severe infections, or cardiovascular diseases106.
An overall estimation of all experimental and clinical
observations on the biological role of zinc seems to
infer that zinc supply may be useful in reducing infec-
tion relapse, restoring immune efficiency in aging, and
preventing age-related degenerative diseases. Zinc is
not stored in the body, and excess intake results in
reduced absorption and increased excretion. Neverthe-
less, there are documented cases of acute and chronic
zinc poisoning107.
Rice bran (MGN-3/Biobran)
MGN-3, a biological response modifier, is an arabinoxy-
lan with a xylose in its main chain and an arabinose
polymer in its side chain. It is derived from rice bran
that has been enzymatically modified by an extract of
the mushroom Hyphomycetes mycelia108. An in vitro in-
vestigation revealed increased tumor necrosis factor-α
and IFN-γ production by peripheral blood lympho-
cytes treated with MGN-3109. MGN-3 was found to
enhance anti-CD95 antibody-induced apoptosis in a
human leukemic cell line110. In addition, it has been
studied in a limited number of patients with HIV dis-
ease or cancer, with improvement in NK cell function
and disease activity over time109. Animal model studies
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have reported increased NK cell activity in aged mice
supplemented with rice bran (MGN-3/Biobran)111,112.
Further studies on NK function in aged humans are
needed to ascertain the benefits of this biological
response modifier on age.
Conclusion
Aging is a universal phenomenon that affects nearly all
animal species. According to Helfand et al.113, aging can
be described as: (1) an inevitable consequence of being
a multicellular organism; (2) being associated with a
random, passive decline in function; (3) leading to a
global loss of homeostasis over time; and (4) being
associated with increasing mortality. This review article
aimed to provide a new insight into NK/NKT activity
with age progression in relation to longevity. Also, a
rationale was provided for possible strategies and
nutrient supplementations in subjects in order to keep
the immune response under control for healthy aging
and longevity.
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